Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

NCT: NCT03142152 · RECRUITING

NCT IDNCT03142152
StatusRECRUITING
Start Date2018-01-01
Completion2030-12-31

Brief Summary

The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).

Frequently Asked Questions

What is The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR?

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR is a clinical trial registered under NCT03142152. Current status: RECRUITING.

What is the status of NCT03142152?

The current status of NCT03142152 (The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR) is: RECRUITING.

When did The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR start?

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR started on 2018-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑